Review



a20 b cell lymphoma cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 97
      Buy from Supplier

    Structured Review

    ATCC a20 b cell lymphoma cells
    A20 B Cell Lymphoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1376 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a20+b+cell+lymphoma/A20/pm42314554-57-12-26
    Average 97 stars, based on 1376 article reviews
    a20 b cell lymphoma cells - by Bioz Stars, 2026-10
    97/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Transglutaminase-mediated conjugation
    Article Snippet: .. A20 B cell lymphoma, CT26 colon carcinoma, EMT6 mouse mammary carcinoma cells (ATCC) were cultured in Complete RPMI 1640 (RPMI1640+10% FBS (Gibco)) at 37° C. and 5% CO2. .. A20 B cell lymphoma, CT26 colon carcinoma, EMT6 mouse mammary carcinoma cells (ATCC) were cultured in Complete RPMI 1640 (RPMI1640+10% FBS (Gibco)) at 37° C. and 5% CO2.

    Article Title: Transglutaminase-mediated conjugation
    Article Snippet: .. A20 B cell lymphoma, CT26 colon carcinoma, EMT6 mouse mammary carcinoma cells (ATCC) were cultured in Complete RPMI 1640 (RPMI1640+10% FBS (Gibco)) at 37° C. and 5% CO2. .. A20 B cell lymphoma, CT26 colon carcinoma, EMT6 mouse mammary carcinoma cells (ATCC) were cultured in Complete RPMI 1640 (RPMI1640+10% FBS (Gibco)) at 37° C. and 5% CO2.

    Article Title: Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies
    Article Snippet: .. MDA-MB-453 and MDA-MB-468 breast carcinoma, and EL-4 T-cell lymphoma cells (all ATCC, Manassas, VA) were cultured in DMEM (Gibco, Thermo Fisher Scientific, Darmstadt, Germany), A20 B-cell lymphoma and K562 erythroleukemia cells (both ATCC), and CEM.NKR and RMA/neo T lymphoblastoid cells (kindly provided by Alexander Steinle, Goethe University, Frankfurt, Germany) in RPMI 1640 medium (Gibco, Thermo Fisher Scientific). .. All media were supplemented with 10% heat-inactivated FBS (Capricorn Scientific, Ebsdorfergrund, Germany), 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin (all Gibco), and 50 μM β-mercaptoethanol (Sigma-Aldrich, Merck, Darmstadt, Germany) for A20 cells.

    Generated:

    Article Title: Intratumoral immunotherapy relies on B and T cell collaboration
    Article Snippet: Anti-mouse CD20 (18B12) was purchased from Absolute Antibody. .. A20 B cell lymphoma, B16-F10 melanoma, 4T1 breast cancer, and CT26 colon carcinoma lines were obtained from the American Type Culture Collection, The H11 pre-B cell line was generated from a C57BL/6 mouse as previously described ( 76 ). .. Tumor cells were cultured in complete medium (RPMI 1640 and Dulbecco’s modified Eagle’s medium for B16-F10; Cellgro) containing 10% fetal bovine serum (FBS; HyClone), penicillin (100 U/ml), streptomycin (100 μg/ml), and 50 μM 2-mercaptoethanol (Gibco).

    Multiple Displacement Amplification:

    Article Title: Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies
    Article Snippet: .. MDA-MB-453 and MDA-MB-468 breast carcinoma, and EL-4 T-cell lymphoma cells (all ATCC, Manassas, VA) were cultured in DMEM (Gibco, Thermo Fisher Scientific, Darmstadt, Germany), A20 B-cell lymphoma and K562 erythroleukemia cells (both ATCC), and CEM.NKR and RMA/neo T lymphoblastoid cells (kindly provided by Alexander Steinle, Goethe University, Frankfurt, Germany) in RPMI 1640 medium (Gibco, Thermo Fisher Scientific). .. All media were supplemented with 10% heat-inactivated FBS (Capricorn Scientific, Ebsdorfergrund, Germany), 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin (all Gibco), and 50 μM β-mercaptoethanol (Sigma-Aldrich, Merck, Darmstadt, Germany) for A20 cells.



    Similar Products

    a20 b cell lymphoma cells  (ATCC)
    97
    ATCC a20 b cell lymphoma cells
    A20 B Cell Lymphoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a20+b+cell+lymphoma/A20/pm42314554-57-12-26
    Average 97 stars, based on 1 article reviews
    a20 b cell lymphoma cells - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    a20 murine b cell lymphoma tumor  (ATCC)
    97
    ATCC a20 murine b cell lymphoma tumor
    A20 Murine B Cell Lymphoma Tumor, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a20+b+cell+lymphoma/A20/pmc13111737-251-0-9
    Average 97 stars, based on 1 article reviews
    a20 murine b cell lymphoma tumor - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    murine b cell lymphoma a20 cell line  (ATCC)
    97
    ATCC murine b cell lymphoma a20 cell line
    Murine B Cell Lymphoma A20 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a20+b+cell+lymphoma/A20/pm42021682-60-1-11
    Average 97 stars, based on 1 article reviews
    murine b cell lymphoma a20 cell line - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    murine b lymphoma a20 cells  (ATCC)
    97
    ATCC murine b lymphoma a20 cells
    Val-ILs affect immunosuppressive cells and B lymphoma growth BALB/c mice were s.c. injected with 10 6 <t>A20</t> cells. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) on days 6, 9, and 12. Analyses were performed on day 15. (A) UMAP data frame and heatmap following FC showing the expression levels of the nine antigens targeted by Val-ILs-Combo among immune cells detected in the TME. Mean normalized data of n = 8 untreated mice. (B) NPs reduced the tumor volumes measured in vivo. Image of tumors isolated ex vivo , n = 8 mice per group, four did not develop tumors (black cross). (C) UMAP data showing that Val-ILs-Combo affected the repartition of immune cells in the TME. (D) NPs affected the repartition of immune cells in the spleen. (E and F) Val-ILs-Combo reduced the amount of Th17, Tregs, MDSCs, TAMs, or macrophages, in the TME (E) and the spleen (F). (G) Histogram showing the number of antigens targeted by the NPs and found repressed on the cell surface of various immune cell populations. (H) FC on TAMs in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (I) FC on tDCs in the TME and DCs in the spleen, to identify the percentage of activated MHC II + DCs. (J) FC on CD4 + and CD8 + T-Ly in the TDLNs showing an increase in these populations. (K) FC showing that Val-ILs-Combo reduced the amount of Th17 and Tregs in the TDLNs. (L) Tumor growth volumes measured in vivo following the injection of Val-ILs-Combo and/or αPD-1 (200 μg). Image of tumors isolated ex vivo , n = 8 mice per group. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG and are calculated using a two-tailed unpaired Student’s t test. See also .
    Murine B Lymphoma A20 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a20+b+cell+lymphoma/A20/pmc13006431-441-16-21
    Average 97 stars, based on 1 article reviews
    murine b lymphoma a20 cells - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    b lymphoma a20 cells atcc  (ATCC)
    97
    ATCC b lymphoma a20 cells atcc
    Val-ILs affect immunosuppressive cells and B lymphoma growth BALB/c mice were s.c. injected with 10 6 <t>A20</t> cells. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) on days 6, 9, and 12. Analyses were performed on day 15. (A) UMAP data frame and heatmap following FC showing the expression levels of the nine antigens targeted by Val-ILs-Combo among immune cells detected in the TME. Mean normalized data of n = 8 untreated mice. (B) NPs reduced the tumor volumes measured in vivo. Image of tumors isolated ex vivo , n = 8 mice per group, four did not develop tumors (black cross). (C) UMAP data showing that Val-ILs-Combo affected the repartition of immune cells in the TME. (D) NPs affected the repartition of immune cells in the spleen. (E and F) Val-ILs-Combo reduced the amount of Th17, Tregs, MDSCs, TAMs, or macrophages, in the TME (E) and the spleen (F). (G) Histogram showing the number of antigens targeted by the NPs and found repressed on the cell surface of various immune cell populations. (H) FC on TAMs in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (I) FC on tDCs in the TME and DCs in the spleen, to identify the percentage of activated MHC II + DCs. (J) FC on CD4 + and CD8 + T-Ly in the TDLNs showing an increase in these populations. (K) FC showing that Val-ILs-Combo reduced the amount of Th17 and Tregs in the TDLNs. (L) Tumor growth volumes measured in vivo following the injection of Val-ILs-Combo and/or αPD-1 (200 μg). Image of tumors isolated ex vivo , n = 8 mice per group. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG and are calculated using a two-tailed unpaired Student’s t test. See also .
    B Lymphoma A20 Cells Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a20+b+cell+lymphoma/A20/pm41763215-258-55-59
    Average 97 stars, based on 1 article reviews
    b lymphoma a20 cells atcc - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    a20 mouse b lymphoma cells  (ATCC)
    97
    ATCC a20 mouse b lymphoma cells
    Val-ILs affect immunosuppressive cells and B lymphoma growth BALB/c mice were s.c. injected with 10 6 <t>A20</t> cells. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) on days 6, 9, and 12. Analyses were performed on day 15. (A) UMAP data frame and heatmap following FC showing the expression levels of the nine antigens targeted by Val-ILs-Combo among immune cells detected in the TME. Mean normalized data of n = 8 untreated mice. (B) NPs reduced the tumor volumes measured in vivo. Image of tumors isolated ex vivo , n = 8 mice per group, four did not develop tumors (black cross). (C) UMAP data showing that Val-ILs-Combo affected the repartition of immune cells in the TME. (D) NPs affected the repartition of immune cells in the spleen. (E and F) Val-ILs-Combo reduced the amount of Th17, Tregs, MDSCs, TAMs, or macrophages, in the TME (E) and the spleen (F). (G) Histogram showing the number of antigens targeted by the NPs and found repressed on the cell surface of various immune cell populations. (H) FC on TAMs in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (I) FC on tDCs in the TME and DCs in the spleen, to identify the percentage of activated MHC II + DCs. (J) FC on CD4 + and CD8 + T-Ly in the TDLNs showing an increase in these populations. (K) FC showing that Val-ILs-Combo reduced the amount of Th17 and Tregs in the TDLNs. (L) Tumor growth volumes measured in vivo following the injection of Val-ILs-Combo and/or αPD-1 (200 μg). Image of tumors isolated ex vivo , n = 8 mice per group. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG and are calculated using a two-tailed unpaired Student’s t test. See also .
    A20 Mouse B Lymphoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a20+b+cell+lymphoma/A20/pm41680851-52-6-37
    Average 97 stars, based on 1 article reviews
    a20 mouse b lymphoma cells - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier

    Image Search Results


    Val-ILs affect immunosuppressive cells and B lymphoma growth BALB/c mice were s.c. injected with 10 6 A20 cells. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) on days 6, 9, and 12. Analyses were performed on day 15. (A) UMAP data frame and heatmap following FC showing the expression levels of the nine antigens targeted by Val-ILs-Combo among immune cells detected in the TME. Mean normalized data of n = 8 untreated mice. (B) NPs reduced the tumor volumes measured in vivo. Image of tumors isolated ex vivo , n = 8 mice per group, four did not develop tumors (black cross). (C) UMAP data showing that Val-ILs-Combo affected the repartition of immune cells in the TME. (D) NPs affected the repartition of immune cells in the spleen. (E and F) Val-ILs-Combo reduced the amount of Th17, Tregs, MDSCs, TAMs, or macrophages, in the TME (E) and the spleen (F). (G) Histogram showing the number of antigens targeted by the NPs and found repressed on the cell surface of various immune cell populations. (H) FC on TAMs in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (I) FC on tDCs in the TME and DCs in the spleen, to identify the percentage of activated MHC II + DCs. (J) FC on CD4 + and CD8 + T-Ly in the TDLNs showing an increase in these populations. (K) FC showing that Val-ILs-Combo reduced the amount of Th17 and Tregs in the TDLNs. (L) Tumor growth volumes measured in vivo following the injection of Val-ILs-Combo and/or αPD-1 (200 μg). Image of tumors isolated ex vivo , n = 8 mice per group. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG and are calculated using a two-tailed unpaired Student’s t test. See also .

    Journal: Cell Reports Medicine

    Article Title: Valrubicin-loaded immunoliposomes targeting antigens on immunosuppressive cells to circumvent resistance to cancer immunotherapy

    doi: 10.1016/j.xcrm.2026.102632

    Figure Lengend Snippet: Val-ILs affect immunosuppressive cells and B lymphoma growth BALB/c mice were s.c. injected with 10 6 A20 cells. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) on days 6, 9, and 12. Analyses were performed on day 15. (A) UMAP data frame and heatmap following FC showing the expression levels of the nine antigens targeted by Val-ILs-Combo among immune cells detected in the TME. Mean normalized data of n = 8 untreated mice. (B) NPs reduced the tumor volumes measured in vivo. Image of tumors isolated ex vivo , n = 8 mice per group, four did not develop tumors (black cross). (C) UMAP data showing that Val-ILs-Combo affected the repartition of immune cells in the TME. (D) NPs affected the repartition of immune cells in the spleen. (E and F) Val-ILs-Combo reduced the amount of Th17, Tregs, MDSCs, TAMs, or macrophages, in the TME (E) and the spleen (F). (G) Histogram showing the number of antigens targeted by the NPs and found repressed on the cell surface of various immune cell populations. (H) FC on TAMs in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (I) FC on tDCs in the TME and DCs in the spleen, to identify the percentage of activated MHC II + DCs. (J) FC on CD4 + and CD8 + T-Ly in the TDLNs showing an increase in these populations. (K) FC showing that Val-ILs-Combo reduced the amount of Th17 and Tregs in the TDLNs. (L) Tumor growth volumes measured in vivo following the injection of Val-ILs-Combo and/or αPD-1 (200 μg). Image of tumors isolated ex vivo , n = 8 mice per group. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG and are calculated using a two-tailed unpaired Student’s t test. See also .

    Article Snippet: In this study, we utilized the murine T lymphoma EL4 cells (ATCC, TIB-39, C57BL/6 strain), the murine B lymphoma A20 cells (ATCC, TIB-208, BALB/c strain), the murine breast cancer 4T1 cells (ATCC, CRL-2539, BALB/c strain) and the murine Lewis lung carcinoma LLC1 (LL/2) cells (ATCC, CRL-1642, C57BL/6 strain).

    Techniques: Injection, Expressing, In Vivo, Isolation, Ex Vivo, Two Tailed Test